Clinical Trial Update: A Study Assessing KB407 for the Treatment of Cystic Fibrosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating KB407 for cystic fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• KB407

Snippet

Sponsor: Krystal Biotech, Inc. | Conditions: Cystic Fibrosis | Phase 1 | Status: RECRUITING